| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
alicare is a West Harrison, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
InnFocus, Inc., an early stage company pioneering a microsurgical solution for glaucoma.InnFocus is an ophthalmology company founded in 2003 with extensive biomaterials experience that develops and provides next generation products for glaucoma surgery. Glaucoma is a disease for which there is no cure, is the second leading cause of blindness in the world and afflicts an estimated 60 million people worldwide.
Columbus Regional Healthcare System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Columbus Regional Healthcare System is based in Whiteville, NC. You can find more information on Columbus Regional Healthcare System at www.crhealthcare.org
Weiler Engineering is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.